Lp-PLA2-IN-17
Lp-PLA2-IN-17 (Compound 39) is an inhibitor of Lp-PLA2. Lp-PLA2-IN-17 can be used to study disorders involving the hydrolysis of oxidized lipids into two inflammatory substances with the participation of Lp-PLA2.
For research use only. We do not sell to patients.
- CAS No.: 1818842-74-8
- Formula: C24H14Cl2F3N5O2
- Molecular Weight:532.30
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Phospholipase Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 1818842-74-8
-
Molecular Weight 532.30
-
Formula C24H14Cl2F3N5O2
-
SMILES
FC(F)(C1=CC(OC2=CC=C(COC3=NC4=NC=C(N4C=C3)C5=CN=CN=C5)C=C2Cl)=CC=C1Cl)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Lp-PLA2-IN-17 Related Classifications
HY-160637 Related Classifications
Powered by Bioz
- Lp-PLA2-IN-17
- 1818842-74-8
- Phospholipase
- atherosclerosis
- diabetes mellitus
- diabetic eye disease
- diabetic brain disease
- hypertension
- angina pectoris
- rheumatoid arthritis
- stroke
- myocardial infarction
- post-ischemia and reperfusion
- psoriasis
- inflammatory diseases of the brain (e.g.
- Alzheimer's disease)
- various neuropsychiatric diseases (e.g.
- schizophrenia)
- ischemia-reperfusion injury
- sepsis
- acute and chronic inflammatory diseases
- Inhibitor
- inhibitor
- inhibit